KMTS — KESTRA MEDICAL TECHNOLOGIES, LTD.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1877184 ·
Last close
$27.14
Market Cap
$1.59B
52W High
$30.00
52W Low
$17.34
ADV30
343,287
Next earnings
2026-12-14
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jul 2026 | 30,971,000 | 17,498,000 | -37,657,000 | -44,087,000 | 347,355,000 | 68,558,000 | 124,998,000 |
| Apr 2026 | — | — | — | — | — | — | — |
| Jan 2026 | 24,552,000 | 12,906,000 | -34,765,000 | -34,166,000 | 379,342,000 | 291,321,000 | 91,353,000 |
| Oct 2025 | 22,565,000 | 11,424,000 | -31,755,000 | -32,785,000 | 246,701,000 | 175,424,000 | 82,620,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-87,724,000
Investing CF
$-216,397,000
Financing CF
$171,465,000
CapEx
$-35,486,000
Dividends Paid
$-495,000
Buybacks
—
EPS Diluted TTM
$-2.67
As of
2026-09-20
Balance + Analyst (yfinance extras)
Retained Earnings
$-695,948,000
Inventory
$7,438,000
Receivables
$15,406,000
ST Investments
$130,353,000
EBIT TTM
$-142,000,000
Pretax Income TTM
$-149,562,000
Interest Exp TTM
$7,562,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$95,126,000
EBITDA
$-126,032,000
Free Cash Flow
$-75,763,376
Enterprise Value
$1,189,424,000
Total Cash
$196,434,000
Total Debt
$46,791,000
Shares Out
58,603,121
Trailing EPS
$-2.43
Book Value
$4.45
ROE
-56.6%
ROA
-25.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Apr 2026 | 95,126,000 | -134,741,000 | -131,612,000 | 358,465,000 | 98,807,000 | 259,658,000 | -81,703,000 |
| Apr 2025 | 59,815,000 | -106,378,000 | -113,814,000 | 295,744,000 | 90,338,000 | 205,406,000 | -77,608,000 |
| Apr 2024 | 27,814,000 | -85,063,000 | -94,120,000 | 45,949,000 | 255,326,000 | -209,377,000 | -72,235,000 |
| Apr 2023 | 7,630,000 | -80,421,000 | -84,238,000 | 38,656,000 | 156,234,000 | -117,578,000 | -69,642,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.02
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATEC | Alphatec Holdings, Inc. | $1.56B | $10.12 | — |
| NVCR | NovoCure Ltd | $1.84B | $15.84 | — |
| CNMD | CONMED Corp | $1.36B | $45.38 | — |
| LMAT | LEMAITRE VASCULAR INC | $1.86B | $81.52 | — |
| XRAY | DENTSPLY SIRONA Inc. | $1.87B | $9.40 | — |
News headlines (Yahoo Finance, 1h cache)
Kestra Medical Technologies (KMTS) Could Be 17% Undervalued Following Raised Revenue Outlook
2026-09-22 02:10 · Yahoo
Kestra Medical (KMTS) Raises Outlook. Can Better Reimbursement Support Scale?
2026-09-17 21:14 · Yahoo
KESTRA MEDICAL TECHNOLOGIES, LTD. Q1 2027 Earnings Call Summary
2026-09-15 12:30 · Yahoo
Kestra Medical Technologies Ltd (KMTS) (Q1 2027) Earnings Call Highlights: Revenue Jumps 60% as ...
2026-09-15 07:00 · Yahoo
Kestra Medical Technologies Q1 Earnings Call Highlights
2026-09-14 22:03 · Yahoo
Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue Estimates
2026-09-14 21:25 · Yahoo
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
2026-09-14 20:01 · Yahoo
AI Infrastructure Stock Forgent Power, Cardiovascular Play Kestra In Earnings Spotlight
2026-09-11 18:56 · Yahoo
Kestra Names Daniel Finney Vice President of Research & Development
2026-09-10 10:00 · Yahoo
Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for
2026-09-07 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.